Tower Research Capital LLC (Trc) Jazz Pharmaceuticals PLC Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,025 shares of JAZZ stock, worth $310,909. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,025
Previous 893
238.75%
Holding current value
$310,909
Previous $99,000
275.76%
% of portfolio
0.01%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding JAZZ
# of Institutions
553Shares Held
59.2MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$632 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$620 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$260 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$228 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$209 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.44B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...